- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 11-21-2024 11:39am EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 247.0M | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 30.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.70 - $7.37 | Next Earning Date: | 11-05-2024 |
| Revenue: | $64,488,000 | Revenue Growth: | 9.85% |
| Revenue Growth (this year): | 7.34% | Revenue Growth (next year): | 20.25% |
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
PR Newswire
7 hours ago
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Simply Wall St.
13 days ago
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00
TipRanks
15 days ago
SOPHiA GENETICS Faces Financial Challenges Amid Losses
Simply Wall St.
15 days ago
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations
GuruFocus.com
15 days ago
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
Thomson Reuters StreetEvents
15 days ago
Q3 2024 Sophia Genetics SA Earnings Call
MT Newswires
16 days ago
Sophia Genetics Hires George Cardoza as CFO
PR Newswire
16 days ago
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
Compare SOPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.